Literature DB >> 6074000

Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

M J Perley, D M Kipnis.   

Abstract

The plasma insulin responses of normal weight and obese, diabetic, and nondiabetic subjects to intravenous glucose was only 30-40% of that seen after oral glucose, indicating that alimentary mechanism(s) in addition to the arterial blood sugar concentration regulate insulin secretion. Observations made in subjects with diverted portal circulation indicate that the alimentary insulinogenic mechanism is located in the intestinal tract. The insulinogenic potency of the alimentary and glycemic stimuli expressed in terms of insulin secretion per gram of glucose were remarkably similar within each group of individuals. Between these groups, however, there were considerable differences. Obesity, with or without associated diabetes, was associated with a true hypersecretory responsiveness, whereas diabetes was characterized, with or without obesity, by a marked impairment in insulin secretion. The experimental design used in these studies permitted quantitation of the magnitude of the glycemic component of an oral glucose load. As a consequence of impaired insulin secretion, a greater than normal proportion of the oral glucose load escapes initial hepatic extraction in the maturity-onset diabetic and enters the peripheral circulation. Therefore, in the noninsulin-requiring maturity-onset diabetic, the glycemic insulinogenic stimulus for a given oral glucose load is significantly greater than in normal subjects and accounts for the excessive plasma insulin responses observed late in the course of an oral glucose tolerance test.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6074000      PMCID: PMC292948          DOI: 10.1172/JCI105685

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Studies of tissue permeability. IV. The distribution of glucose between plasma and muscle.

Authors:  D M KIPNIS; E HELMREICH; C F CORI
Journal:  J Biol Chem       Date:  1959-01       Impact factor: 5.157

2.  The physiologic significance of the secretion of endogenous insulin into the portal circulation. I. Comparison of the effects of glucagon-free insulin adminstered via the portal vein and via a peripheral vein on the magnitude of hypoglycemia and peripheral glucose utilization.

Authors:  L L MADISON; R H UNGER
Journal:  J Clin Invest       Date:  1958-05       Impact factor: 14.808

3.  Quantitative relations between the oral and intravenous glucose tolerance curves.

Authors:  R O SCOW; J CORNFIELD
Journal:  Am J Physiol       Date:  1954-12

4.  The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus.

Authors:  E Cerasi; R Luft
Journal:  Acta Endocrinol (Copenh)       Date:  1967-06

5.  Intestinal factors in the control of insulin secretion.

Authors:  N McIntyre; C D Holdsworth; D S Turner
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

6.  Plasma insulin and growth hormone levels in obesity and diabetes.

Authors:  R S Yalow; S M Glick; J Roth; S A Berson
Journal:  Ann N Y Acad Sci       Date:  1965-10-08       Impact factor: 5.691

7.  Effect upon insulin secretion of physiologic doses of glucagon administered via the portal vein.

Authors:  H Ketterer; A M Eisentraut; R H Unger
Journal:  Diabetes       Date:  1967-05       Impact factor: 9.461

8.  Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects.

Authors:  M Perley; D M Kipnis
Journal:  Diabetes       Date:  1966-12       Impact factor: 9.461

9.  Stimulation of insulin secretion by pancreozymin.

Authors:  R C Meade; H A Kneubuhler; W J Schulte; J J Barboriak
Journal:  Diabetes       Date:  1967-03       Impact factor: 9.461

10.  Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.

Authors:  H S Seltzer; E W Allen; A L Herron; M T Brennan
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

View more
  196 in total

1.  The enteral insulin-stimulation after Whipple's operation.

Authors:  J F Rehfeld; F Stadil; H Baden; K Fischerman
Journal:  Diabetologia       Date:  1975-06       Impact factor: 10.122

2.  An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells.

Authors:  Jeffrey M Sturek; J David Castle; Anthony P Trace; Laura C Page; Anna M Castle; Carmella Evans-Molina; John S Parks; Raghavendra G Mirmira; Catherine C Hedrick
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

3.  cAMP-independent effects of GLP-1 on β cells.

Authors:  Jelena Kolic; Patrick E MacDonald
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

Review 4.  The Macronutrients, Appetite, and Energy Intake.

Authors:  Alicia L Carreiro; Jaapna Dhillon; Susannah Gordon; Kelly A Higgins; Ashley G Jacobs; Breanna M McArthur; Benjamin W Redan; Rebecca L Rivera; Leigh R Schmidt; Richard D Mattes
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

Review 5.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

6.  Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes.

Authors:  D H Jensen; K Aaboe; J E Henriksen; A Vølund; J J Holst; S Madsbad; T Krarup
Journal:  Diabetologia       Date:  2012-05       Impact factor: 10.122

Review 7.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

8.  Diabetogenic action of streptozotocin: relationship of dose to metabolic response.

Authors:  A Junod; A E Lambert; W Stauffacher; A E Renold
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

Review 9.  Insulin analogues: new therapies for type 2 diabetes mellitus.

Authors:  M Angelyn Bethel; Mark N Feinglos
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

10.  Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy.

Authors:  G Pehling; P Tessari; J E Gerich; M W Haymond; F J Service; R A Rizza
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.